Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning

Start

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

Previous Story

Boeing Reports Strongest Revenue in 6 Years

Next Story

Morton Mintz, Muckraking Crusader for Consumers, Dies at 103